Compare US Global Jets ETF (JETS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
US Global Jets ETF vs State Street SPDR S&P Biotech ETF — how do they compare? US Global Jets ETF trades at $31.63, while State Street SPDR S&P Biotech ETF trades at $159.05. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, US Global Jets ETF nearer its low. Which is the better fit depends on your goals.
| JETS | XBI | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $33.53 | $164.28 |
52-Week Low | $23.64 | $86.92 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JETS trades at $31.63, up 0.6% on the day, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights airline earnings beats and government rebates for plane retrofits, though fuel cost volatility remains a headwind. The ETF focuses on U.S. airline operators, offering exposure to travel demand but facing cyclical risks.
Outlook is mixed: lower oil prices support profitability, but geopolitical tensions and fuel swings pose risks. JETS provides diversified airline exposure but underperforms defense-focused peers on expense ratios and drawdowns. Investor sentiment is cautious amid earnings revisions and sector comparisons.
XBI trades at $158.81, up 0.49% today, with a bullish technical signal supported by moving averages. The ETF shows strong momentum with a 17% monthly gain and 75% annual return, driven by biotech sector strength. Analyst coverage is limited to one hold rating, while recent news highlights institutional buying interest and positive sector developments including M&A activity and drug trial successes.
The outlook remains positive given biotech's breakout from multi-year bear markets, though elevated volatility and policy risks persist. Key opportunities include AI-driven drug discovery and sustained M&A momentum, while risks involve sector-specific volatility and regulatory uncertainty. The ETF's equal-weight approach provides diversified exposure to biotech innovation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
